Merck COVID-19 pill success slams Moderna shares, shakes up health care sector
Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies.
Best Dslr Camera under 200 via FOX BUSINESS NEWS Markets
https://ift.tt/2YcvR8Z
0 Comments:
Post a Comment